Spanu Pennestri, Teresa
 Distribuzione geografica
Continente #
EU - Europa 7.437
NA - Nord America 7.036
AS - Asia 5.239
SA - Sud America 1.136
AF - Africa 141
OC - Oceania 33
Continente sconosciuto - Info sul continente non disponibili 9
Totale 21.031
Nazione #
US - Stati Uniti d'America 6.864
DE - Germania 3.247
SG - Singapore 2.050
CN - Cina 2.004
BR - Brasile 948
SE - Svezia 856
IT - Italia 744
UA - Ucraina 473
PL - Polonia 465
FR - Francia 404
GB - Regno Unito 362
VN - Vietnam 263
IE - Irlanda 250
IN - India 192
FI - Finlandia 177
ID - Indonesia 169
RU - Federazione Russa 139
TR - Turchia 130
CA - Canada 92
AR - Argentina 72
AT - Austria 69
BD - Bangladesh 68
HK - Hong Kong 54
BE - Belgio 49
JP - Giappone 43
IQ - Iraq 40
MX - Messico 39
ZA - Sudafrica 35
ES - Italia 33
NL - Olanda 33
EC - Ecuador 31
IR - Iran 31
MA - Marocco 29
AU - Australia 27
PK - Pakistan 25
SA - Arabia Saudita 24
CH - Svizzera 21
PH - Filippine 21
KR - Corea 19
VE - Venezuela 19
CO - Colombia 17
CZ - Repubblica Ceca 16
CL - Cile 14
AE - Emirati Arabi Uniti 13
EG - Egitto 12
LT - Lituania 12
UZ - Uzbekistan 12
PT - Portogallo 11
CI - Costa d'Avorio 10
KZ - Kazakistan 10
PE - Perù 10
PY - Paraguay 10
UY - Uruguay 10
DZ - Algeria 9
KE - Kenya 9
MT - Malta 9
MY - Malesia 9
DO - Repubblica Dominicana 8
VA - Santa Sede (Città del Vaticano) 8
BG - Bulgaria 7
EU - Europa 7
GR - Grecia 7
JM - Giamaica 7
JO - Giordania 7
NG - Nigeria 7
NP - Nepal 7
ET - Etiopia 6
NZ - Nuova Zelanda 6
SD - Sudan 6
TN - Tunisia 6
AZ - Azerbaigian 5
LV - Lettonia 5
OM - Oman 5
PA - Panama 5
RS - Serbia 5
TT - Trinidad e Tobago 5
DK - Danimarca 4
EE - Estonia 4
HU - Ungheria 4
IL - Israele 4
RO - Romania 4
TW - Taiwan 4
AM - Armenia 3
BO - Bolivia 3
GE - Georgia 3
HN - Honduras 3
KG - Kirghizistan 3
LK - Sri Lanka 3
LU - Lussemburgo 3
PS - Palestinian Territory 3
SK - Slovacchia (Repubblica Slovacca) 3
SN - Senegal 3
TZ - Tanzania 3
A2 - ???statistics.table.value.countryCode.A2??? 2
AF - Afghanistan, Repubblica islamica di 2
AL - Albania 2
BA - Bosnia-Erzegovina 2
BB - Barbados 2
BH - Bahrain 2
CR - Costa Rica 2
Totale 20.994
Città #
Chandler 1.063
Singapore 916
Ashburn 709
Hangzhou 604
Warsaw 392
Jacksonville 346
Beijing 327
Ann Arbor 254
San Mateo 250
Dublin 242
Nürnberg 223
Woodbridge 213
Nanjing 212
New York 211
Wilmington 195
Fairfield 174
Dearborn 173
Los Angeles 164
Jakarta 153
Seattle 149
Houston 141
Munich 111
Boston 110
Hefei 106
Milan 102
São Paulo 100
Rome 99
Izmir 98
Ho Chi Minh City 93
Chicago 91
Moscow 86
Lawrence 79
Cattolica 78
The Dalles 78
Marseille 77
Nanchang 72
Buffalo 67
Dallas 63
Hanoi 62
Redwood City 60
Princeton 57
Frankfurt am Main 56
Helsinki 55
Cambridge 53
Hong Kong 51
Kraków 51
Kunming 47
Vienna 46
Brussels 45
Bremen 42
Shenyang 41
Boardman 39
Guangzhou 38
London 36
North Bergen 36
Tianjin 36
Mountain View 35
Rio de Janeiro 30
Tokyo 30
Denver 29
Hebei 29
Zhengzhou 28
Jiaxing 27
Nuremberg 27
Santa Clara 27
Brooklyn 26
Changsha 26
Montreal 26
Norwalk 26
Toronto 26
Lancaster 25
Redmond 24
Atlanta 23
Kent 23
Belo Horizonte 22
Falls Church 22
Fremont 22
Phoenix 22
Stockholm 22
Chennai 21
San Francisco 21
Johannesburg 20
Shanghai 20
Augusta 19
Baghdad 19
Leawood 18
Campinas 17
Haiphong 17
Turku 17
University Park 17
Paris 16
Pune 16
Brasília 15
Porto Alegre 15
Seoul 15
Guarulhos 14
Jinan 14
Poplar 14
Quito 14
Simi Valley 14
Totale 10.422
Nome #
Intestinal parasites isolated in a large teaching hospital, Italy, 1 May 2006 to 31 December 2008 451
Educational interventions alone and combined with port protector reduce the rate of central venous catheter infection and colonization in respiratory semi-intensive care unit. 420
Factors associated with mortality in bacteremic patients with hematologic malignancies. 345
Predictors of mortality in bloodstream infections caused by Klebsiella pneumoniae carbapenemase-producing K. pneumoniae: importance of combination therapy 344
Factors associated with mortality in bacteremic patients with haematologic malignancies 337
Clinical outcomes of Pseudomonas aeruginosa pneumonia in intensive care unit patients 337
In vitro Evaluation of BACT/ALERT® VIRTUO®, BACT/ALERT 3D®, and BACTEC™ FX Automated Blood Culture Systems for Detection of Microbial Pathogens Using Simulated Human Blood Samples 322
Predictors of mortality in bloodstream infections caused by Klebsiella pneumoniae carbapenemase-producing K. pneumoniae: importance of combination therapy 297
Diabetic foot infections: a comprehensive overview 290
Antifungal Susceptibility Profiles of Bloodstream Yeast Isolates by Sensititre YeastOne: a Nine-Year Experience at a Large Italian Teaching Hospital 276
A rapid diagnostic workflow for cefotaxime-resistant Escherichia coli and Klebsiella pneumoniae detection from blood cultures by MALDI-TOF mass spectrometry 263
Empyema caused by Prevotella bivia complicating an unusual case of spontaneous chylothorax. 256
Predictors of mortality in patients with bloodstream infections caused by extended-spectrum-beta-lactamase-producing Enterobacteriaceae: importance of inadequate initial antimicrobial treatment. 255
Performance of two resin-containing blood culture media in detection of bloodstream infections and in direct matrix-assisted laser desorption ionization-time of flight mass spectrometry (MALDI-TOF MS) broth assays for isolate identification: clinical comparison of the BacT/Alert Plus and Bactec Plus systems 233
Optimized Use of the MALDI BioTyper System and FilmArray BCID Panel for the Direct Identification of Microbial Pathogens from Positive Blood Cultures 232
Predictors of Mortality in Bloodstream Infections Caused by Klebsiella pneumoniae Carbapenemase-Producing K. pneumoniae: Importance of Combination Therapy 229
Biofilm production by Candida species and inadequate antifungal therapy as predictors of mortality for patients with candidemia. 226
Application of MALDI-TOF mass spectrometry in clinical diagnostic microbiology 216
Costs of bloodstream infections caused by Escherichia coli and influence of extended-spectrum-beta-lactamase production and inadequate initial antibiotic therapy. 207
Factors associated with mortality in bacteremic patients with hematologic malignancies. 205
Identifying patients harboring extended-spectrum-beta-lactamase-producing Enterobacteriaceae on hospital admission: derivation and validation of a scoring system. 198
Effect of combination therapy containing a high-dose carbapenem on mortality in patients with carbapenem-resistant Klebsiella pneumoniae bloodstream infection 198
Development of a Multiplex PCR Platform for the Rapid Detection of Bacteria, Antibiotic Resistance, and Candida in Human Blood Samples 198
High-dose daptomycin for cardiac implantable electronic device-related infective endocarditis caused by staphylococcal small-colony variants 187
In Vivo Emergence of Tigecycline Resistance in Multidrug-Resistant Klebsiella pneumoniae and Escherichia coli 186
Performance of two resin-containing blood culture media in detection of bloodstream infections and in direct matrix-assisted laser desorption ionization-time of flight mass spectrometry (MALDI-TOF MS) broth assays for isolate identification: clinical comparison of the BacT/Alert Plus and Bactec Plus systems 185
Comparison of Mycoplasma IES, Mycofast Revolution and Mycoplasma IST2 to detect genital mycoplasmas in clinical samples. 184
Antibiotic usage and risk of colonization and infection with antibiotic-resistant bacteria: a hospital population-based study 179
Bloodstream infections caused by extended-spectrum-beta-lactamase- producing Escherichia coli: risk factors for inadequate initial antimicrobial therapy. 178
Clinical and microbiological outcome in septic patients with extremely low 25-hydroxyvitamin D levels at initiation of critical care 177
Vancomycin versus cefazolin prophylaxis for cerebrospinal shunt placement in a hospital with a high prevalence of meticillin-resistant Staphylococcus aureus 174
Antimicrobial susceptibility testing of pathogens isolated from blood culture: a performance comparison of Accelerate Pheno (TM) and VITEK (R) 2 systems with the broth microdilution method 174
Carbapenemase-producing Klebsiella pneumoniae and hematologic malignancies 173
Direct use of eazyplex® SuperBug CRE assay from positive blood cultures in conjunction with inpatient infectious disease consulting for timely appropriate antimicrobial therapy in Escherichia coli and Klebsiella pneumoniae bloodstream infections 168
Bloodstream infections caused by extended-spectrum-beta-lactamase- producing Escherichia coli: risk factors for inadequate initial antimicrobial therapy 167
Incidence and clinical impact of extended-spectrum-beta-lactamase (ESBL) production and fluoroquinolone resistance in bloodstream infections caused by Escherichia coli in patients with hematological malignancies 166
Predictive models for identification of hospitalized patients harboring KPC-producing Klebsiella pneumoniae 166
Efficient Recovery of Candida auris and Five Other Medically Important Candida Species from Blood Cultures Containing Clinically Relevant Concentrations of Antifungal Agents 161
Pertussis in infants less than 6 months of age and household contacts, Italy April 2014 159
Characteristics of staphylococcus aureus bacteraemia and predictors of early and late mortality 159
Risk factors and predictors of mortality of methicillin-resistant Staphylococcus aureus (MRSA) bacteremia in HIV-infected patients 158
Antifungal susceptibility profiles of bloodstream yeast isolates by Sensititre YeastOne over nine years at a large Italian teaching hospital 156
A) High levels of dual resistance to clarithromycin and metronidazole and in vitro activity of levofloxacin against Helicobacter pylori isolates from patients after failure of therapy. 154
Characterisation and risk-factor profiling of P. aeruginosa urinary tract infections: pinpointing those likely to be caused by multidrug-resistant strains 154
High dose tigecycline in critically ill patients with severe infections due to multidrug-resistant bacteria 153
Linezolid plasma and intrapulmonary concentrations in critically ill obese patients with ventilator-associated pneumonia: intermittent vs continuous administration 153
Tsukamurella tyrosinosolvens and Rhizobium radiobacter sepsis presenting with septic pulmonary emboli 150
Incidence and clinical impact of extended-spectrum-beta-lactamase (ESBL) production and fluoroquinolone resistance in bloodstream infections caused by Escherichia coli in patients with hematological malignancies 149
Global climate change and wound care: case study of an off-season vibrio alginolyticus infection in a healthy man 149
Costs of bloodstream infections caused by Escherichia coli and influence of extended-spectrum-beta-lactamase production and inadequate initial antibiotic therapy 147
Diagnosis and Treatment of Bacterial Pneumonia in Critically Ill Patients with COVID-19 Using a Multiplex PCR Assay: A Large Italian Hospital’s Five-Month Experience 147
Carbapenemase-producingKlebsiella pneumoniaeand Hematologic Malignancies 143
Bloodstream infections caused by extended -spectrum-beta-lactamase-producing Klebsiella pneumoniae: risk factors, molecular epidemiology, and clinical outcome 142
Direct MALDI-TOF MS Testing from Positive Blood Cultures for Rapid Identification of Bloodstream Infection-Causing Anaerobic Bacteria 142
Multidrug-resistant Proteus mirabilis bloodstream infections: risk factors and outcomes 140
Catheter-related bacteremia by Cupriavidus metallidurans 140
Trimethoprim-sulfamethoxazole therapy for patients with carbapenemase-producing Klebsiella pneumoniae infections: retrospective single-center case series 140
Prediction models to identify hospitalized patients at risk of being colonized or infected with multidrug-resistant Acinetobacter baumannii calcoaceticus complex. 137
Efficacy of Ceftazidime-avibactam Salvage Therapy in Patients with Infections Caused by KPC-producing Klebsiella pneumoniae 136
Multidrug-resistant Pseudomonas aeruginosa bloodstream infections: risk factors and mortality. 135
. Incidence and clinical impact of extended-spectrum-beta-lactamase (ESBL) production and fluoroquinolone resistance in bloodstream infections caused by Escherichia coli in patients with hematological malignancies. 135
Evaluation of the New NucliSENS EasyQ KPC test for rapid detection of Klebsiella pneumoniae carbapenemase genes (blaKPC) 134
T2Bacteria magnetic resonance assay for the rapid detection of ESKAPEc pathogens directly in whole blood 134
Multidrug-Resistant Proteus mirabilis Bloodstream Infections: Risk Factors and Outcomes 133
Comparing BioFire FilmArray BCID2 and BCID panels for direct detection of bacterial pathogens and antimicrobial resistance genes from positive blood cultures 132
Global climate change and wound care: case study of an off-season vibrio alginolyticus infection in a healthy man. 129
Assessment of linezolid resistance mechanisms among Staphylococcus epidermidis causing bacteraemia in Rome, Italy 128
Evaluation of the new VITEK 2 extended-spectrum beta-lactamase (ESBL) test for rapid detection of ESBL production in Enterobacteriaceae isolates 128
Derivation and Validation of a Scoring System to Identify Patients with Bacteremia and Hematological Malignancies at Higher Risk for Mortality 128
Multidrug-resistant Pseudomonas aeruginosa bloodstream infections: risk factors and mortality 127
Resource-saving advice from an infectious diseases specialist team in a large university hospital: an exportable model? 127
Derivation and validation of a scoring system to identify patients with bacteremia and hematological malignancies at higher risk for mortality 126
Intraventricular versus intravenous colistin for the treatment of extensively drug resistant Acinetobacter baumannii meningitis 125
Simulated Pediatric Blood Cultures to Assess the Inactivation of Clinically Relevant Antimicrobial Drug Concentrations in Resin-Containing Bottles 124
Early assessment of blood culture negativity as a potential support tool for antimicrobial stewardship 123
Compliance of clinical microbiology laboratories with recommendations for the diagnosis of bloodstream infections 123
Glycopeptide resistance among coagulase-negative staphylococci that cause bacteremia: epidemiological and clinical findings from a case-control study 121
Clinical impact of pulmonary sampling site in the diagnosis of ventilator-associated pneumonia: A prospective study using bronchoscopic bronchoalveolar lavage 121
FETR-ALS Study Protocol: A Randomized Clinical Trial of Fecal Microbiota Transplantation in Amyotrophic Lateral Sclerosis 121
Implementation of the eazyplex(®) CSF direct panel assay for rapid laboratory diagnosis of bacterial meningitis: 32-month experience at a tertiary care university hospital 120
Infections caused by KPC-producing Klebsiella pneumoniae: differences in therapy and mortality in a multicentre study 119
A 72-h intervention for improvement of the rate of optimal antibiotic therapy in patients with bloodstream infections 119
Risk factors for mortality and cost implications of complicated intra-abdominal infections in critically ill patients 119
Ventriculitis due to Staphylococcus lugdunensis: two case reports 118
Linezolid plasma and intrapulmonary concentrations in critically ill obese patients with ventilator-associated pneumonia: intermittent vs continuous administration 118
Infections caused by KPC-producing Klebsiella pneumoniae: differences in therapy and mortality in a multicentre study--authors' response 118
Lice, rodents, and many hopes: a rare disease in a young refugee 118
Simplified Testing Method for Direct Detection of Carbapenemase-Producing Organisms from Positive Blood Cultures Using the NG-Test Carba 5 Assay 118
Reply to Seligman 117
Molecular identification of Leuconostoc mesenteroides as a cause of brain abscess in an immunocompromised patient 117
High-dose daptomycin for cardiac implantable electronic device-related infective endocarditis caused by staphylococcal small-colony variants 116
Global climate change and wound care: case study of an off-season vibrio alginolyticus infection in a healthy man 116
Direct maldi-tof mass spectrometry assay of blood culture broths for rapid identification of Candida species causing bloodstream infections: an observational study in two large microbiology laboratories 115
Incidence and antimicrobial resistance trends in bloodstream infections caused by ESKAPE and Escherichia coli at a large teaching hospital in Rome, a 9-year analysis (2007–2015) 115
Characterization of clinical isolates of Enterobacteriaceae from Italy by the BD Phoenix extended-spectrum beta-lactamase detection method 115
Evaluation of the New NucliSENS EasyQ KPC Test for Rapid Detection of Klebsiella pneumoniae Carbapenemase Gene (blaKPC) 114
Risk Factors for Mortality in Adult COVID-19 Patients Who Develop Bloodstream Infections Mostly Caused by Antimicrobial-Resistant Organisms: Analysis at a Large Teaching Hospital in Italy 114
EUCAST rapid antimicrobial susceptibility testing of blood cultures positive for Escherichia coli or Klebsiella pneumoniae: experience of three laboratories in Italy 111
Bacterial isolates from severe infections and their antibiotic susceptibility patterns in Italy: a nationwide study in the hospital setting 110
Risk factors and mortality of healthcare-associated and community-acquired Staphylococcus aureus bacteraemia 109
Totale 17.058
Categoria #
all - tutte 75.797
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 75.797


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021870 0 0 0 0 0 139 203 55 181 51 202 39
2021/20221.345 108 111 44 79 67 82 44 235 59 82 210 224
2022/20233.024 364 412 203 425 198 336 149 273 380 93 124 67
2023/20241.353 84 349 39 83 64 197 86 77 15 60 127 172
2024/20252.656 73 75 208 89 239 73 90 117 428 244 543 477
2025/20264.275 1.055 223 469 937 1.314 277 0 0 0 0 0 0
Totale 21.201